<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37102989</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2559</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Histopathology</Title><ISOAbbreviation>Histopathology</ISOAbbreviation></Journal><ArticleTitle>Vascular/epithelial changes as late sequelae after recovery from SARS-COV-2 infection: an in-vivo comparative study.</ArticleTitle><Pagination><StartPage>229</StartPage><EndPage>241</EndPage><MedlinePgn>229-241</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/his.14930</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">While there is partial evidence of lung lesions in patients suffering from long COVID there are substantial concerns about lung remodelling sequelae after COVID-19 pneumonia. The aim of the present retrospective comparative study was to ascertain morphological features in lung samples from patients undergoing tumour resection several months after SARS-CoV-2 infection.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">The severity of several lesions with a major focus on the vascular bed was analysed in 2 tumour-distant lung fragments of 41 cases: 21 SARS-CoV-2 (+) lung tumour (LT) patients and 20 SARS-CoV-2 (-) LT patients. A systematic evaluation of several lesions was carried out by combining their scores into a grade of I-III. Tissue SARS-CoV-2 genomic/subgenomic transcripts were also investigated. Morphological findings were compared with clinical, laboratory and radiological data. SARS-CoV-2 (+) LT patients with previous pneumonia showed more severe parenchymal and vascular lesions than those found in SARS-CoV-2 (+) LT patients without pneumonia and SARS-CoV-2 (-) LT patients, mainly when combined scores were used. SARS-CoV-2 viral transcripts were not detected in any sample. SARS-CoV-2 (+) LT patients with pneumonia showed a significantly higher radiological global injury score. No other associations were found between morphological lesions and clinical data.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To our knowledge, this is the first study that, after a granular evaluation of tissue parameters, detected several changes in lungs from patients undergoing tumour resection after SARS-CoV-2 infection. These lesions, in particular vascular remodelling, could have an important impact overall on the future management of these frail patients.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Histopathology published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pezzuto</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunardi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vedovelli</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olteanu</LastName><ForeName>Gheorghe E</ForeName><Initials>GE</Initials><Identifier Source="ORCID">0000-0001-5921-4634</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Discipline of Pulmonology, Centre for Research and Innovation in Personalized Medicine of Respiratory Diseases, 'Victor Babes' University of Medicine and Pharmacy, Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortarezza</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Pellegrin</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0934-7452</Identifier><AffiliationInfo><Affiliation>University Hospital of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melan</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faccioli</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Franceschi</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University Hospital of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giraudo</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Vecchio</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinello</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasello</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgery, Oncology and Gastroenterology, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregori</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navalesi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rea</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiavon</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabrese</LastName><ForeName>Fiorella</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5351-9226</Identifier><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova Medical School, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BIRD213993</GrantID><Agency>University of Padova</Agency><Country/></Grant><Grant><GrantID>2020A08</GrantID><Agency>Intesa San Paolo Vita Bank</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Histopathology</MedlineTA><NlmUniqueID>7704136</NlmUniqueID><ISSNLinking>0309-0167</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">histology</Keyword><Keyword MajorTopicYN="N">lung cancer</Keyword><Keyword MajorTopicYN="N">vascular remodelling</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>10</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37102989</ArticleId><ArticleId IdType="doi">10.1111/his.14930</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) dashboard. Date last update: November 22 2022. Date last access: November 27 2022. https://covid19.who.int/</Citation></Reference><Reference><Citation>Calabrese F, Pezzuto F, Fortarezza F et&#xa0;al. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European pulmonary pathologists. Virchows Arch. 2020; 477; 359-372.</Citation></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M et&#xa0;al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 2020; 383; 120-128.</Citation></Reference><Reference><Citation>Carsana L, Sonzogni A, Nasr A et&#xa0;al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect. Dis. 2020; 20; 1135-1140.</Citation></Reference><Reference><Citation>Borczuk AC, Salvatore SP, Seshan SV et&#xa0;al. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and new York City. Mod. Pathol. 2020; 33; 2156-2168.</Citation></Reference><Reference><Citation>Bryce C, Grimes Z, Pujadas E et&#xa0;al. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod. Pathol. 2021; 34; 1456-1467.</Citation></Reference><Reference><Citation>Faverio P, Luppi F, Rebora P et&#xa0;al. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study. Respir. Res. 2022; 23; 65.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y et&#xa0;al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397; 220-232.</Citation></Reference><Reference><Citation>Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for radiologists on COVID-19: an update-radiology scientific expert panel. Radiology 2020; 296; E113-E114.</Citation></Reference><Reference><Citation>Konopka KE, Perry W, Huang T, Farver CF, Myers JL. Usual interstitial pneumonia is the Most common finding in surgical lung biopsies from patients with persistent interstitial lung disease following infection with SARS-CoV-2. EClinicalMedicine 2021; 42; 101209.</Citation></Reference><Reference><Citation>Chraba&#x144;ska M, Mazur A, St&#x119;plewska K. Histopathological pulmonary findings of survivors and autopsy COVID-19 cases: a bi-center study. Medicine (Baltimore) 2022; 101; e32002.</Citation></Reference><Reference><Citation>Roden AC, Boland JM, Johnson TF et&#xa0;al. Late complications of COVID-19. Arch. Pathol. Lab. Med. 2022; 146; 791-804.</Citation></Reference><Reference><Citation>Aesif SW, Bribriesco AC, Yadav R et&#xa0;al. Pulmonary pathology of COVID-19 following 8&#x2009;weeks to 4 months of severe disease: a report of three cases, including one with bilateral lung transplantation. Am. J. Clin. Pathol. 2021; 155; 506-514.</Citation></Reference><Reference><Citation>Bharat A, Querrey M, Markov NS et&#xa0;al. Lung transplantation for patients with severe COVID-19. Sci. Transl. Med. 2020; 124; eabe4282.</Citation></Reference><Reference><Citation>Bharat A, Machuca TN, Querrey M et&#xa0;al. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. Lancet Respir. Med. 2021; 9; 487-497.</Citation></Reference><Reference><Citation>Coronavirus disease 2019 (COVID-19) treatment guidelines. Bethesda, MD: National Institutes of Health (US), 2021.</Citation></Reference><Reference><Citation>Calabrese F, Pezzuto F, Fortarezza F et&#xa0;al. Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure. J. Pathol. 2021; 254; 173-184.</Citation></Reference><Reference><Citation>Lunardi F, Fortarezza F, Vedovelli L et&#xa0;al. Lower gene expression of angiotensin converting enzyme 2 receptor in lung tissues of smokers with COVID-19 pneumonia. Biomolecules 2021; 11(6); 796.</Citation></Reference><Reference><Citation>W&#xf6;lfel R, Corman VM, Guggemos W et&#xa0;al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581; 465-469.</Citation></Reference><Reference><Citation>Francone M, Iafrate F, Masci GM et&#xa0;al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur. Radiol. 2020; 30; 6808-6817.</Citation></Reference><Reference><Citation>R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2021. https://www.R-progject.org/.</Citation></Reference><Reference><Citation>Sjoberg DD, Whiting K, Curry M et&#xa0;al. Reproducible summary&#xa0;tables with the gtsummary package. R J 2021; 13; 570-580.</Citation></Reference><Reference><Citation>Patil I. Visualizations with statistical details: the &#x2018;ggstatsplot&#x2019; approach. J Open Source Softw 2021; 6; 3167.</Citation></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K et&#xa0;al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020; 26; 1017-1032.</Citation></Reference><Reference><Citation>Boehm A, Luger AK, Schmitz K et&#xa0;al. A spark of hope: histopathological and functional recovery after critical COVID-19. Infection 2022; 50; 263-267.</Citation></Reference><Reference><Citation>Lee HE, Yi ES, Rabatin JT, Bohman JK, Roden AC. Histopathologic findings in lungs of patients treated with extracorporeal membrane oxygenation. Chest 2018; 153; 825-833.</Citation></Reference><Reference><Citation>Antonio GE, Wong KT, Hui DS et&#xa0;al. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology 2003; 228; 810-815.</Citation></Reference><Reference><Citation>Sadhukhan P, Ugurlu MT, Hoque MO. Effect of COVID-19 on lungs: focusing on prospective malignant phenotypes. Cancer (Basel) 2020; 12; 3822.</Citation></Reference><Reference><Citation>Pogatchnik BP, Swenson KE, Sharifi H, Bedi H, Berry GJ, Guo HH. Radiology-pathology correlation demonstrating organizing pneumonia in a patient who recovered from COVID-19. Am. J. Respir. Crit. Care Med. 2020; 202; 598-599.</Citation></Reference><Reference><Citation>Rai DK, Kumar S, Sahay N. Post-COVID-19 pulmonary fibrosis: a case series and review of literature. J. Family Med. Prim. Care 2021; 10; 2028-2031.</Citation></Reference><Reference><Citation>Diaz A, Bujnowski D, McMullen P et&#xa0;al. Pulmonary parenchymal changes in COVID-19 survivors. Ann. Thorac. Surg. 2022; 114; 301-310.</Citation></Reference><Reference><Citation>Hammoud SH, Wehbe Z, Abdelhady S, Kobeissy F, Eid AH, El-Yazbi AF. Dysregulation of angiotensin converting enzyme 2 expression and function in comorbid disease conditions possibly contributes to coronavirus infectious disease 2019 complication severity. Mol. Pharmacol. 2021; 99; 17-28.</Citation></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004; 203; 631-637.</Citation></Reference><Reference><Citation>Suzuki YJ, Gychka SG. SARS-CoV-2 spike protein elicits cell signaling in human host cells: implications for possible consequences of COVID-19 vaccines. Vaccines (Basel) 2021; 9; 36.</Citation></Reference><Reference><Citation>Halawa S, Pullamsetti SS, Bangham CRM et&#xa0;al. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat. Rev. Cardiol. 2022; 19; 314-331.</Citation></Reference><Reference><Citation>Rendeiro AF, Ravichandran H, Bram Y et&#xa0;al. The spatial landscape of lung pathology during COVID-19 progression. Nature 2021; 593; 564-569.</Citation></Reference><Reference><Citation>Cobes N, Guernou M, Lussato D et&#xa0;al. Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series. Eur. J. Nucl. Med. Mol. Imaging 2020; 47; 2453-2460.</Citation></Reference><Reference><Citation>Dhawan RT, Gopalan D, Howard L et&#xa0;al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir. Med. 2021; 9; 107-116.</Citation></Reference><Reference><Citation>Evbuomwan O, Endres W, Tebeila T, Engelbrecht G. Identification and follow-up of COVID-19 related matching ventilation and perfusion defects on functional imaging using VQ SPECT/CT. Nucl. Med. Mol. Imaging 2022; 24; 1-7.</Citation></Reference><Reference><Citation>Lang M, Som A, Carey D et&#xa0;al. Pulmonary vascular manifestations of COVID-19 pneumonia. Radiol. Cardiothorac. Imaging 2020; 2; e200277.</Citation></Reference><Reference><Citation>Idilman IS, Telli Dizman G, Ardali Duzgun S et&#xa0;al. Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy. Eur. Radiol. 2021; 31; 1090-1099.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>